Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Apitz

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Transplantation|April 10, 2019
Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMRHeiner Latus, Pauline Hachmann, Inga Voges, et al.
International Journal of Cardiology|September 8, 2018
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018Marius M Hoeper, Christian Apitz, Ekkehard Grünig, et al.
Heart (British Cardiac Society)|July 30, 2017
Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndromeHeiner Latus, Mohamed S Nassar, James Wong, et al.
Journal of Clinical Medicine|June 12, 2026
Congenital Heart Defects and Mental Health: Stress, Psychological Treatment Use, and COVID-19-Related Burden in Young Patients-Lessons from the P-BAHn StudyPaul C Helm, Jule Josephine Oster, Claudia Niessner, et al.
NPJ Genomic Medicine|March 26, 2025
Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertensionSofia Karl, Ekkehard Grünig, Memoona Shaukat, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Pulmonary arterial hypertension in congenital heart disease - Part I]Harald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pneumologie (Stuttgart, Germany)|May 24, 2024
[Pulmonary hypertension in adults with congenital heart disease in light of the 2022-ESC-PAH guidelines - Part II: Supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesions, left ventricular disorders, univentricular hearts), interventions, intensive care, follow-up, future perspectives]Harald Kaemmerer, Gerhard Paul Diller, Stephan Achenbach, et al.
Cardiovascular Diagnosis and Therapy|November 8, 2024
Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspectsHarald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pulmonary Circulation|October 3, 2022
Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD studyHumberto García Aguilar, Matthias Gorenflo, D Dunbar Ivy, et al.
Cardiovascular Diagnosis and Therapy|November 8, 2024
Pulmonary hypertension in adults with congenital heart defects (ACHDs) in light of the 2022 ESC PAH guidelines-part II: supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesion, left ventricular disease, univentricular hearts), interventions, intensive care, ACHD follow-up, future perspectiveHarald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Transplantation|April 10, 2019
Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMRHeiner Latus, Pauline Hachmann, Inga Voges, et al.
International Journal of Cardiology|September 8, 2018
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018Marius M Hoeper, Christian Apitz, Ekkehard Grünig, et al.
Heart (British Cardiac Society)|July 30, 2017
Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndromeHeiner Latus, Mohamed S Nassar, James Wong, et al.
Journal of Clinical Medicine|June 12, 2026
Congenital Heart Defects and Mental Health: Stress, Psychological Treatment Use, and COVID-19-Related Burden in Young Patients-Lessons from the P-BAHn StudyPaul C Helm, Jule Josephine Oster, Claudia Niessner, et al.
NPJ Genomic Medicine|March 26, 2025
Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertensionSofia Karl, Ekkehard Grünig, Memoona Shaukat, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Pulmonary arterial hypertension in congenital heart disease - Part I]Harald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pneumologie (Stuttgart, Germany)|May 24, 2024
[Pulmonary hypertension in adults with congenital heart disease in light of the 2022-ESC-PAH guidelines - Part II: Supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesions, left ventricular disorders, univentricular hearts), interventions, intensive care, follow-up, future perspectives]Harald Kaemmerer, Gerhard Paul Diller, Stephan Achenbach, et al.
Cardiovascular Diagnosis and Therapy|November 8, 2024
Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspectsHarald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pulmonary Circulation|October 3, 2022
Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD studyHumberto García Aguilar, Matthias Gorenflo, D Dunbar Ivy, et al.
Cardiovascular Diagnosis and Therapy|November 8, 2024
Pulmonary hypertension in adults with congenital heart defects (ACHDs) in light of the 2022 ESC PAH guidelines-part II: supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesion, left ventricular disease, univentricular hearts), interventions, intensive care, ACHD follow-up, future perspectiveHarald Kaemmerer, Gerhard Paul Diller, Ingo Dähnert, et al.
Pageof 10